Αποτελέσματα αναζήτησης - George D. Demetri
- Εμφανίζονται 1 - 20 Αποτελέσματα από 128
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
Advances in the treatment of gastrointestinal stromal tumours από Ian Judson, George D. Demetri
Έκδοση 2007Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human a... από Thomas F. Tedder, Cary Isaacs, T J Ernst, George D. Demetri, David A. Adler, Christine M. Distèche
Έκδοση 1989Artigo -
13
-
14
-
15
-
16
A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib από T. V. Patel, Jeffrey A. Morgan, George D. Demetri, Suzanne George, Robert G. Maki, Michael Quigley, Benjamin D. Humphreys
Έκδοση 2008Carta -
17
-
18
Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors από George D. Demetri, Yanfeng Wang, Elisabeth Wehrle, Amy Racine, Zariana Nikolova, Charles D. Blanke, Heikki Joensuu, Margaret von Mehren
Έκδοση 2009Artigo -
19
Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma από George D. Demetri, Christopher D.�M. Fletcher, Elisabetta Mueller, Pasha Sarraf, Ryan Naujoks, Natalee Campbell, Bruce M. Spiegelman, Samuel Singer
Έκδοση 1999Artigo -
20
Εργαλεία αναζήτησης:
Σχετικά θέματα
Medicine
Internal medicine
Oncology
Cancer
Pathology
Stromal cell
Cancer research
Biology
Surgery
GiST
Imatinib
Myeloid leukemia
Chemotherapy
Sarcoma
Clinical trial
Gastroenterology
Genetics
Sunitinib
Gene
Imatinib mesylate
Soft tissue sarcoma
Adverse effect
Soft tissue
Receptor
Clinical endpoint
Phases of clinical research
Tyrosine-kinase inhibitor
Cell biology
Stromal tumor
Biochemistry